14 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
of directors to make, alter, amend or repeal our amended and restated by-laws; and
require supermajority votes of the holders of our common stock to amend
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
amended and restated by-laws; and
require supermajority votes of the holders of our common stock to amend specified provisions of our third amended
S-1/A
dbc8 n9sejspop7
13 Oct 22
IPO registration (amended)
10:51am
S-1
4ckm2wa2
23 Sep 22
IPO registration
4:12pm
DRS/A
7jd9te5boteq 3aoos3x
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
htrqjwgvddk9um1tvlgi
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
l8p3ie 3xi
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
2rnnownn9wxpq
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
y6s1cr4
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
kc54lfd 1wh
4 Feb 22
Draft registration statement (amended)
12:00am
DRS
8hepz6n
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next